Literature DB >> 25074658

Antibiotic susceptibility of ica-positive and ica-negative MRSA in different phases of biofilm growth.

Shivani Chopra1, Kusum Harjai1, Sanjay Chhibber1.   

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) has emerged as a clinically relevant pathogen because of its resistance to antibiotics and its ability to form potent biofilm. Both ica-negative as well as ica-positive MRSA strains are known to produce biofilm. In the present study, these strains were grown in biofilm mode and susceptibility of these to antibiotics was assessed. Our study suggests that antibiotic susceptibility of MRSA biofilm depends on the biochemical composition of its matrix. The biofilm matrix of ica-positive MRSA was mainly composed of poly-intercellular adhesion (PIA), whereas eDNA was a major constituent of ica-negative MRSA. The results showed that MRSA in planktonic growth was susceptible to clindamycin, vancomycin and minocycline. However, the MIC and MBC of vancomycin for the mature biofilm of ica-negative MRSA was 16 and 32 μg ml(-1), respectively. On the contrary, the MIC and MBC of vancomycin for ica-positive MRSA was >1024 μg ml(-1). The effect of vancomycin and minocycline on young and old biofilms was also determined. Vancomycin was quite effective in eradicating the young biofilm formed by ica-negative MRSA; however, it was completely ineffective on the biofilm of ica-positive MRSA. Minocycline at its highest clinical achievable concentration was found to be quite effective in eradicating the young biofilm formed by both the strains. The enzyme-linked immunosorbent assay (ELISA) results and dot blot assay suggest that the presence of ica locus influenced PIA production, which probably contributed towards the failure of vancomycin in eradicating the biofilm formed by ica-positive strain. However, none of the antibiotics used in this study was effective in eradicating the mature biofilms.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25074658     DOI: 10.1038/ja.2014.96

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  39 in total

1.  Growing problem of methicillin resistant staphylococci--Indian scenario.

Authors:  S Verma; S Joshi; V Chitnis; N Hemwani; D Chitnis
Journal:  Indian J Med Sci       Date:  2000-12

Review 2.  Biofilm formation in Staphylococcus implant infections. A review of molecular mechanisms and implications for biofilm-resistant materials.

Authors:  Carla Renata Arciola; Davide Campoccia; Pietro Speziale; Lucio Montanaro; John William Costerton
Journal:  Biomaterials       Date:  2012-06-12       Impact factor: 12.479

3.  The estimation of the bactericidal power of the blood.

Authors:  A A Miles; S S Misra; J O Irwin
Journal:  J Hyg (Lond)       Date:  1938-11

4.  Comparative assessment of antibiotic susceptibility of coagulase-negative staphylococci in biofilm versus planktonic culture as assessed by bacterial enumeration or rapid XTT colorimetry.

Authors:  Nuno Cerca; Silvia Martins; Filipe Cerca; Kimberly K Jefferson; Gerald B Pier; Rosário Oliveira; Joana Azeredo
Journal:  J Antimicrob Chemother       Date:  2005-06-24       Impact factor: 5.790

5.  Antibiotic resistance in an in vitro subgingival biofilm model.

Authors:  M J Sedlacek; C Walker
Journal:  Oral Microbiol Immunol       Date:  2007-10

6.  Association between methicillin susceptibility and biofilm regulation in Staphylococcus aureus isolates from device-related infections.

Authors:  Eoghan O'Neill; Clarissa Pozzi; Patrick Houston; Davida Smyth; Hilary Humphreys; D Ashley Robinson; James P O'Gara
Journal:  J Clin Microbiol       Date:  2007-02-28       Impact factor: 5.948

7.  Fibronectin, fibrinogen, and laminin act as mediators of adherence of clinical staphylococcal isolates to foreign material.

Authors:  M Herrmann; P E Vaudaux; D Pittet; R Auckenthaler; P D Lew; F Schumacher-Perdreau; G Peters; F A Waldvogel
Journal:  J Infect Dis       Date:  1988-10       Impact factor: 5.226

8.  A novel Staphylococcus aureus biofilm phenotype mediated by the fibronectin-binding proteins, FnBPA and FnBPB.

Authors:  Eoghan O'Neill; Clarissa Pozzi; Patrick Houston; Hilary Humphreys; D Ashley Robinson; Anthony Loughman; Timothy J Foster; James P O'Gara
Journal:  J Bacteriol       Date:  2008-03-28       Impact factor: 3.490

Review 9.  ica and beyond: biofilm mechanisms and regulation in Staphylococcus epidermidis and Staphylococcus aureus.

Authors:  James P O'Gara
Journal:  FEMS Microbiol Lett       Date:  2007-04-10       Impact factor: 2.742

10.  Antibiotic susceptibility of coagulase-negative staphylococci isolated from very low birth weight babies: comprehensive comparisons of bacteria at different stages of biofilm formation.

Authors:  Yue Qu; Andrew J Daley; Taghrid S Istivan; Suzanne M Garland; Margaret A Deighton
Journal:  Ann Clin Microbiol Antimicrob       Date:  2010-05-27       Impact factor: 3.944

View more
  10 in total

1.  Biofilm Formation of Staphylococcus aureus from Pets, Livestock, and Wild Animals: Relationship with Clonal Lineages and Antimicrobial Resistance.

Authors:  Vanessa Silva; Elisete Correia; José Eduardo Pereira; Camino González-Machado; Rosa Capita; Carlos Alonso-Calleja; Gilberto Igrejas; Patrícia Poeta
Journal:  Antibiotics (Basel)       Date:  2022-06-04

Review 2.  Chromogenic media for MRSA diagnostics.

Authors:  Zhenbo Xu; Yuchao Hou; Brian M Peters; Dingqiang Chen; Bing Li; Lin Li; Mark E Shirtliff
Journal:  Mol Biol Rep       Date:  2016-08-25       Impact factor: 2.316

3.  Methicillin-Resistant Staphylococcus aureus Biofilms and Their Influence on Bacterial Adhesion and Cohesion.

Authors:  Khulood Hamid Dakheel; Raha Abdul Rahim; Vasantha Kumari Neela; Jameel R Al-Obaidi; Tan Geok Hun; Khatijah Yusoff
Journal:  Biomed Res Int       Date:  2016-12-18       Impact factor: 3.411

4.  In vitro Multi-Species Biofilms of Methicillin-Resistant Staphylococcus aureus and Pseudomonas aeruginosa and Their Host Interaction during In vivo Colonization of an Otitis Media Rat Model.

Authors:  Mukesh K Yadav; Sung-Won Chae; Yoon Young Go; Gi Jung Im; Jae-Jun Song
Journal:  Front Cell Infect Microbiol       Date:  2017-04-18       Impact factor: 5.293

5.  Effects of stigmata maydis on the methicillin resistant Staphylococus aureus biofilm formation.

Authors:  Fei Shang; Long Li; Lumin Yu; Jingtian Ni; Xiaolin Chen; Ting Xue
Journal:  PeerJ       Date:  2019-02-26       Impact factor: 2.984

Review 6.  Streptomyces: The biofactory of secondary metabolites.

Authors:  Khorshed Alam; Arpita Mazumder; Suranjana Sikdar; Yi-Ming Zhao; Jinfang Hao; Chaoyi Song; Yanyan Wang; Rajib Sarkar; Saiful Islam; Youming Zhang; Aiying Li
Journal:  Front Microbiol       Date:  2022-09-29       Impact factor: 6.064

7.  Effect of carbon on whole-biofilm metabolic response to high doses of streptomycin.

Authors:  Lindsay M D Jackson; Otini Kroukamp; Gideon M Wolfaardt
Journal:  Front Microbiol       Date:  2015-09-11       Impact factor: 5.640

8.  A novel nitro-dexamethasone inhibits agr system activity and improves therapeutic effects in MRSA sepsis models without antibiotics.

Authors:  Yun Yang; Haibo Li; Hongwu Sun; Li Gong; Ling Guo; Yun Shi; Changzhi Cai; Hao Gu; Zhen Song; Liuyang Yang; Yanan Tong; Chao Wei; Quanming Zou; Hao Zeng
Journal:  Sci Rep       Date:  2016-02-03       Impact factor: 4.379

9.  Broad impact of extracellular DNA on biofilm formation by clinically isolated Methicillin-resistant and -sensitive strains of Staphylococcus aureus.

Authors:  Shinya Sugimoto; Fumiya Sato; Reina Miyakawa; Akio Chiba; Shoichi Onodera; Seiji Hori; Yoshimitsu Mizunoe
Journal:  Sci Rep       Date:  2018-02-02       Impact factor: 4.379

10.  Small-Molecule Compound SYG-180-2-2 to Effectively Prevent the Biofilm Formation of Methicillin-Resistant Staphylococcus aureus.

Authors:  Lulin Rao; Yaoguang Sheng; Jiao Zhang; Yanlei Xu; Jingyi Yu; Bingjie Wang; Huilin Zhao; Xinyi Wang; Yinjuan Guo; Xiaocui Wu; Zengqiang Song; Fangyou Yu; Lingling Zhan
Journal:  Front Microbiol       Date:  2022-01-07       Impact factor: 5.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.